Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Piramal Enterprises Ltd    PEL   INE140A01024

PIRAMAL ENTERPRISES LTD (PEL)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
01/15/2018 01/16/2018 01/17/2018 01/18/2018 01/19/2018 Date
2844(c) 2800(c) 2843(c) 2765(c) 2788.25 Last
98 703 150 242 512 611 149 242 113 371 Volume
-0.58% -1.55% +1.54% -2.74% +0.84% Change
More quotes
Financials ( INR)
Sales 2018 111 B
EBIT 2018 37 846 M
Net income 2018 -
Debt 2018 -
Yield 2018 1,00%
Sales 2019 136 B
EBIT 2019 47 422 M
Net income 2019 -
Debt 2019 -
Yield 2019 1,27%
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 4,35x
Capi. / Sales2019 3,56x
Capitalization 483 B
More Financials
Company
Piramal Enterprises Ltd. engages in pharmaceutical business with its research and development activities.The company operates through the following segments: Pharmaceuticals Manufacturing and Services, Financial Services, and Information Management.The Pharmaceuticals Manufacturing and Services... 
Sector
Pharmaceuticals
Calendar
01/30Earnings Release
More about the company
Latest news on PIRAMAL ENTERPRISES LTD
01/20 PIRAMAL ENTERPRISES : update on proposed rights issue
01/18 PIRAMAL ENTERPRISES : Finance Ltd. forays into hospitality sector
01/16 CIPLA : Over-the-counter route to growth for pharma firms
2017 Birla, piramal-bain, shree court binani
2017 PIRAMAL ENTERPRISES : "Improved Process for the Preparation of Lurasidone and It..
2017 PIRAMAL ENTERPRISES : Trailing twelve month results - piramal enterprises limite..
2017 PIRAMAL ENTERPRISES : Quarterly results - piramal enterprises limited
2017 PIRAMAL ENTERPRISES : Finance to lend more to construction
2017 PIRAMAL ENTERPRISES : acquires Digeplex from Shreya Lifesciences
2017 PIRAMAL ENTERPRISES : Acquires digeplex from shreya life sciences
More news
Sector news : Pharmaceuticals - NEC
01/19 CANADIAN CANNABIS FIRM AURORA IN TAL : sources
01/19 En route to Davos, Macron makes Versailles the place to be
01/19 SHIRE PLC SHIRE PLC : Directorate Change
01/19 At AstraZeneca, fewer drug projects bring big productivity jump
01/18 European shares edge higher as cyclicals back in favour
More sector news : Pharmaceuticals - NEC
Latest Tweets
2017Catch a slice of an exclusive panel discussion b/w , Ajay Piramal, MS Sahoo, ..
2
2017Catch a slice of an exclusive panel discussion b/w , Ajay Piramal, MS Sahoo, ..
1
2017Catch a slice of an exclusive panel discussion b/w , Ajay Piramal, MS Sahoo, ..
1
2017Catch a slice of an exclusive panel discussion b/w , Ajay Piramal, MS Sahoo, ..
1
2017Why billionaire investor Ajay Piramal supports the . Follow for live updates..
5
More tweets
Qtime:33
Chart PIRAMAL ENTERPRISES LTD
Duration : Period :
Piramal Enterprises Ltd Technical Analysis Chart | PEL | INE140A01024 | 4-Traders
Technical analysis trends PIRAMAL ENTERPRISES LTD
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 3 163  INR
Spread / Average Target 13%
Managers
NameTitle
Khushru Burjor Jijina Managing Director
Ajay Gopikisan Piramal Chairman
Vijay Kantilal Shah Chief Operating Officer & Executive Director
Swati Ajay Piramal Vice Chairman
Subramanian V. Ramadorai Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
PIRAMAL ENTERPRISES LTD-3.46%7 564
JOHNSON & JOHNSON5.20%395 886
NOVARTIS0.61%227 592
PFIZER2.65%220 189
ROCHE HOLDING LTD.-5.40%211 135
MERCK AND COMPANY10.24%167 132